N-(3-(5,6-Diethyl-4(3H)-pyrimidone-2-yl)-4-n-propoxyphenyl)-2-(4-methylpiperazin-1-yl)acetamide

ID: ALA4462192

Chembl Id: CHEMBL4462192

PubChem CID: 136197286

Max Phase: Preclinical

Molecular Formula: C24H35N5O3

Molecular Weight: 441.58

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCCOc1ccc(NC(=O)CN2CCN(C)CC2)cc1-c1nc(CC)c(CC)c(=O)[nH]1

Standard InChI:  InChI=1S/C24H35N5O3/c1-5-14-32-21-9-8-17(25-22(30)16-29-12-10-28(4)11-13-29)15-19(21)23-26-20(7-3)18(6-2)24(31)27-23/h8-9,15H,5-7,10-14,16H2,1-4H3,(H,25,30)(H,26,27,31)

Standard InChI Key:  PIOIVHHIGWTEJQ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4462192

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 441.58

Molecular Weight (Monoisotopic): 441.2740

AlogP: 2.54

#Rotatable Bonds: 9

Polar Surface Area: 90.56

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.01

CX Basic pKa: 7.13

CX LogP: 2.26

CX LogD: 2.30

Aromatic Rings: 2

Heavy Atoms: 32

QED Weighted: 0.62

Np Likeness Score: -1.55

References

1. Wang Z, Jiang X, Zhang X, Tian G, Yang R, Wu J, Zou X, Liu Z, Yang X, Wu C, Shi J, Li J, Suo J, Wang Y, Zhang R, Xu Z, Gong X, He Y, Zhu W, Aisa HA, Jiang H, Xu Y, Shen J..  (2019)  Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension.,  62  (10): [PMID:31021628] [10.1021/acs.jmedchem.9b00123]

Source

Source(1):

• Scientific Literature